PathAI Granted FDA Clearance for AISight Dx for Primary Diagnosis in Clinical Settings
PathAI Granted FDA Clearance for AISight Dx for Primary Diagnosis in Clinical Settings

What You Should Know:  – PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its digital pathology image management system, AISight® Dx, for use in primary diagnosis in clinical settings. – The FDA clearance bui...

  • Published date: 01-07-2025 07:41 AM